Document Detail


PP2B-dependent NO production in the medullary thick ascending limb during diabetes.
MedLine Citation:
PMID:  19458119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Calcineurin (PP2B) has recently been shown to be upregulated in the medullary thick ascending limb (mTAL) during diabetes. The mTAL expresses all three isoforms of nitric oxide synthase (NOS), which are subject to phosphoregulation and represent substrates for PP2B. Therefore, we hypothesized that diabetes induces PP2B-dependent upregulation of NOS activity and NO production in the mTAL. Three weeks after injection of streptozotocin (STZ rats) or vehicle (sham rats), mTAL suspensions were prepared for use in functional and biochemical assays. PP2B activity and expression were increased in mTALs from STZ rats compared with sham. Nitrite production was significantly reduced in mTALs from STZ rats compared with sham. However, incubation with the free radical scavenger, tempol, unmasked a significant increase in nitrite production by mTALs from STZ rats. Inhibition of PP2B attenuated the increase in nitrite production and NOS activity evident in mTALs from STZ rats. Analysis of specific NOS isoform activity revealed increased NOS1 and NOS2 activities in mTALs from STZ rats. All three NOS isoform activities were regulated in a PP2B-dependent manner. Western blot analysis detected no differences in NOS isoform expression, although phosphorylation of pThr(495)-NOS3 was significantly reduced in mTALs from STZ rats. Phosphorylation of pSer(852)-NOS1, pSer(633)-NOS3, and pSer(1177)-NOS3 was similar in mTALs from STZ and sham rats. Inhibition of PP2B did not alter the phosphorylation of NOS1 or NOS3 at known sites. In conclusion, while NO bioavailability in mTALs is reduced during diabetes, free radical scavenging with tempol unmasks increased NO production that involves PP2B-dependent activation of NOS1 and NOS2.
Authors:
Jan M Foster; Pamela K Carmines; Jennifer S Pollock
Related Documents :
14658759 - Capn10, a candidate gene responsible for type 2 diabetes mellitus in the oletf rat.
12097799 - Enhanced expression of adhesion molecules of the retinal vascular endothelium in sponta...
170919 - Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (guanosine trip...
14680989 - Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia.
6874989 - A-b similarity-complementarity and accurate empathy.
11903149 - A new approach to the study of latissimus dorsi muscle vasoreactivity in rats.
6435689 - Studies on the metabolic effects of methylthioformycin.
6320559 - Structural localization of the elements of the acetylcholine system in the rat cerebellum.
15452599 - Free radical oxidation and catalytic activity of aconitate hydratase in rat liver under...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-05-20
Journal Detail:
Title:  American journal of physiology. Renal physiology     Volume:  297     ISSN:  1522-1466     ISO Abbreviation:  Am. J. Physiol. Renal Physiol.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-24     Completed Date:  2009-08-27     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  100901990     Medline TA:  Am J Physiol Renal Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  F471-80     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amidines / pharmacology
Animals
Benzylamines / pharmacology
Calcineurin / antagonists & inhibitors,  metabolism*
Cell Survival
Cyclic N-Oxides / pharmacology
Cyclosporine / pharmacology
Diabetes Mellitus, Experimental / complications,  enzymology*
Diabetic Nephropathies / enzymology,  etiology*
Enzyme Activation
Enzyme Inhibitors / pharmacology
Free Radical Scavengers / pharmacology
Kidney Medulla / drug effects,  enzymology*
Loop of Henle / drug effects,  enzymology*
Male
Nitric Oxide / metabolism*
Nitric Oxide Synthase / antagonists & inhibitors,  metabolism*
Nitric Oxide Synthase Type I
Nitric Oxide Synthase Type II / metabolism
Nitric Oxide Synthase Type III / metabolism
Nitrites / metabolism
Ornithine / analogs & derivatives,  pharmacology
Phosphorylation
Rats
Rats, Sprague-Dawley
Spin Labels
Up-Regulation
Grant Support
ID/Acronym/Agency:
HL-60653/HL/NHLBI NIH HHS; R01 HL060653/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Amidines; 0/Benzylamines; 0/Cyclic N-Oxides; 0/Enzyme Inhibitors; 0/Free Radical Scavengers; 0/N(5)-(1-imino-3-butenyl)ornithine; 0/N-(3-(aminomethyl)benzyl)acetamidine; 0/Nitrites; 0/Spin Labels; 2226-96-2/tempol; 31C4KY9ESH/Nitric Oxide; 83HN0GTJ6D/Cyclosporine; E524N2IXA3/Ornithine; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.14.13.39/Nitric Oxide Synthase Type I; EC 1.14.13.39/Nitric Oxide Synthase Type II; EC 1.14.13.39/Nitric Oxide Synthase Type III; EC 1.14.13.39/Nos1 protein, rat; EC 1.14.13.39/Nos2 protein, rat; EC 1.14.13.39/Nos3 protein, rat; EC 3.1.3.16/Calcineurin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Triple loss of function of protein phosphatases type 2C leads to partial constitutive response to en...
Next Document:  Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following tra...